These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative bioinformatic analysis of KRAS, STK11 and KEAP1 (co-)mutations in non-small cell lung cancer with a special focus on KRAS G12C. Boeschen M; Kuhn CK; Wirtz H; Seyfarth HJ; Frille A; Lordick F; Hacker UT; Obeck U; Stiller M; Bläker H; von Laffert M Lung Cancer; 2023 Oct; 184():107361. PubMed ID: 37699269 [TBL] [Abstract][Full Text] [Related]
5. Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced Thummalapalli R; Bernstein E; Herzberg B; Li BT; Iqbal A; Preeshagul I; Santini FC; Eng J; Ladanyi M; Yang SR; Shen R; Lito P; Riely GJ; Sabari JK; Arbour KC JCO Precis Oncol; 2023 Jun; 7():e2300030. PubMed ID: 37384866 [TBL] [Abstract][Full Text] [Related]
6. A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer. Iams WT; Balbach ML; Phillips S; Sacher A; Bestvina C; Velcheti V; Wang X; Marmarelis ME; Sethakorn N; Leal T; Sackstein PE; Kim C; Robinson MA; Mehta K; Hsu R; Nieva J; Patil T; Camidge DR Clin Lung Cancer; 2023 May; 24(3):228-234. PubMed ID: 36841727 [TBL] [Abstract][Full Text] [Related]
7. Activity and resistance to KRAS Ye W; Lu X; Qiao Y; Ou WB Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189108. PubMed ID: 38723697 [TBL] [Abstract][Full Text] [Related]
8. Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany. Stratmann JA; Althoff FC; Doebel P; Rauh J; Trummer A; Hünerlitürkoglu AN; Frost N; Yildirim H; Christopoulos P; Burkhard O; Büschenfelde CMZ; Becker von Rose A; Alt J; Aries SP; Webendörfer M; Kaldune S; Uhlenbruch M; Tritchkova G; Waller CF; Rittmeyer A; Hoffknecht P; Braess J; Kopp HG; Grohé C; Schäfer M; Schumann C; Griesinger F; Kuon J; Sebastian M; Reinmuth N Eur J Cancer; 2024 Apr; 201():113911. PubMed ID: 38377774 [TBL] [Abstract][Full Text] [Related]
9. Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With Luo J; Florez N; Donnelly A; Lou Y; Lu K; Ma PC; Spira AI; Ryan D; Husain H JCO Precis Oncol; 2024 Apr; 8():e2300644. PubMed ID: 38579193 [TBL] [Abstract][Full Text] [Related]
10. A retrospective observational study of the natural history of advanced non-small-cell lung cancer in patients with KRAS p.G12C mutated or wild-type disease. Spira AI; Tu H; Aggarwal S; Hsu H; Carrigan G; Wang X; Ngarmchamnanrith G; Chia V; Gray JE Lung Cancer; 2021 Sep; 159():1-9. PubMed ID: 34293517 [TBL] [Abstract][Full Text] [Related]
11. Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun. Bungaro M; Novello S; Passiglia F Curr Treat Options Oncol; 2022 Dec; 23(12):1699-1720. PubMed ID: 36394791 [TBL] [Abstract][Full Text] [Related]
14. Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib. Bauml JM; Li BT; Velcheti V; Govindan R; Curioni-Fontecedro A; Dooms C; Takahashi T; Duda AW; Odegaard JI; Cruz-Guilloty F; Jin L; Zhang Y; Anderson A; Skoulidis F Lung Cancer; 2022 Apr; 166():270-278. PubMed ID: 34838325 [TBL] [Abstract][Full Text] [Related]
15. Extensive genomic analysis in patients with Jacobsen IC; Spanggaard I; Højgaard M; Belcaid L; Qvortrup C; Yde CW; Schmidt AY; Nielsen FC; Willemoe GL; Dam MS; Lassen U; Staal Rohrberg K Acta Oncol; 2022 Dec; 61(12):1499-1506. PubMed ID: 36529989 [TBL] [Abstract][Full Text] [Related]
16. First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced Ou SI; Jänne PA; Leal TA; Rybkin II; Sabari JK; Barve MA; Bazhenova L; Johnson ML; Velastegui KL; Cilliers C; Christensen JG; Yan X; Chao RC; Papadopoulos KP J Clin Oncol; 2022 Aug; 40(23):2530-2538. PubMed ID: 35167329 [TBL] [Abstract][Full Text] [Related]
17. Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS Ernst SM; van Marion R; Atmodimedjo PN; de Jonge E; Mathijssen RHJ; Paats MS; de Bruijn P; Koolen SL; von der Thüsen JH; Aerts JGJV; van Schaik RHN; Dubbink HJ; Dingemans AC J Thorac Oncol; 2024 Jul; 19(7):995-1006. PubMed ID: 38615940 [TBL] [Abstract][Full Text] [Related]